SX_SYTEMIC RESPONSE TO INJURY AND METABOLIC SUPPORT Flashcards

1
Q

Protein signaling compounds that are essential for both innate and adaptive immunity

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mediate cellular responses including cell migration and turnover, DNA replication, and immunocyte proliferation

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Group of intracellular proteins that are increasingly expressed during time of stress

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Heat shock protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Bind both autologous and foreign proteins and thereby function as intracellular chaperones for ligands such as bacterial DNA and endotoxin

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Heat shock protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Protect cells from deleterious effects of traumatic stress and when released by damaged cells, alert the immune system of the tissue damage

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Heat shock protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Small molecules that are highly reactive due to the presence of unpaired outer orbit electrons

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

ROS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Derived primarily by oxidation of membrane phospholipid, arachidonic acid

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Eicosanoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cause cellular injury to both host cells and invading pathogens through oxidation of unsaturated FA within cell membranes

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

ROS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Composed of subgroups including prostaglandins, prostacyclin, hydroxy eicosatetraenoic acid, thromboxane and leukotriene

Generate a proinflammatory response

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Eicosanoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Omega 3-FA have anti-inflammatory effects including inhibition of TNF release from hepatic Kupffer cells, leukocyte adhesion and migration

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

FA metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Group of proteins that contribute to inflammation, BP control, coagulation, and pain responses

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Kallikrein-Kinin system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Levels of this protease are increased during gram negative bacteremia, hypotension, hemorrhage, endotoxemia, and tissue injury

A

Kallikrein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A hypotensive protease that liberates kinins from blood plasma proteins and is used therapeutically for vasodilation

A

Kallikrein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mediate
-Vasodilation
-Increased cap permeability
-Tissue edema
-Pain pathway activation
-Inhibition of GNG
-Increased bronchoconstriction

A

Kinins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Any of various polypeptide hormones that are formed locally in tissues and cause dilation of bv (vasodilation) and contraction of smooth muscles

A

Kinin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Released at the site of injury, primarily platelets

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Serotonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stimulates
-Vasoconstriction
-Bronchoconstriction
-Platelet aggregation

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Serotonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Receptor blockade of this hormone is associated with decreased production of TNF and IL-1 in edotoxin-treated monocytes

(napapababa ang TNF and IL-1)

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Serotonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Associated with eosinophil and mast cell chemotaxis

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Histamine (H4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Increased release has been documented in hemorrhagic shock, trauma, thermal injury, endotoxemia, and sepsis

A. Cytokines
B. Heat shock proteins
C. ROS
D. Eicosanoids
E. FA metabolites
F. Kallikrein-Kinin system
G. Serotonin
H. Histamine (H4)

A

Histamine (H4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Among earliest responders after injury

Induces muscle breakdown and cachexia through increased catabolism

A. TNF-a (Tumor necrosis factor)
B. IL-1 (Interleukin 1)
C. IL-2 (Interleukin 2)
D. IL-6 (Interleukin 6)
E. IL-8 (Interleukin 8)
F. IFN-y (Interferon-y)

A

TNF-a (Tumor necrosis factor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Induces fever through prostaglandin activity in anterior hypothalamus

Promotes E-endorphin release from pituitary

A. TNF-a (Tumor necrosis factor)
B. IL-1 (Interleukin 1)
C. IL-2 (Interleukin 2)
D. IL-6 (Interleukin 6)
E. IL-8 (Interleukin 8)
F. IFN-y (Interferon-y)

A

IL-1 (Interleukin 1)

22
Q

Promotes lymphocyte proliferation, immunoglobulin production, gut barrier integrity

Attenuated production after major blood loss lead to immunocompromise

A. TNF-a (Tumor necrosis factor)
B. IL-1 (Interleukin 1)
C. IL-2 (Interleukin 2)
D. IL-6 (Interleukin 6)
E. IL-8 (Interleukin 8)
F. IFN-y (Interferon-y)

A

IL-2 (Interleukin 2)

23
Q

Elicited by all immunogenic cells as mediator of acute phase response

Prolongs activated neutrophil survival

A. TNF-a (Tumor necrosis factor)
B. IL-1 (Interleukin 1)
C. IL-2 (Interleukin 2)
D. IL-6 (Interleukin 6)
E. IL-8 (Interleukin 8)
F. IFN-y (Interferon-y)

A

IL-6 (Interleukin 6)

23
Q

Chemoattractant for neutro, baso, esosinophils, lymphocytes

A. TNF-a (Tumor necrosis factor)
B. IL-1 (Interleukin 1)
C. IL-2 (Interleukin 2)
D. IL-6 (Interleukin 6)
E. IL-8 (Interleukin 8)
F. IFN-y (Interferon-y)

A

IL-8 (Interleukin 8)

24
Q

Activates macrophages via TH1 cells that demostrate enhanced phagocytosis and microbial killing

Found in wounds 5-7 days after injury

A. TNF-a (Tumor necrosis factor)
B. IL-1 (Interleukin 1)
C. IL-2 (Interleukin 2)
D. IL-6 (Interleukin 6)
E. IL-8 (Interleukin 8)
F. IFN-y (Interferon-y)

A

IFN-y (Interferon-y)

24
Q

-NSAID prototype
-MOA: Nonselective and irreversible COX inhibitor inhibiting both COX1 and COX 1 isoenzymes

A. Aspirin (ASA)
B. Ketorolac
C. Indomethacin
D. Celecoxib

A

Aspirin (Acetylsalicylic acid, ASA)

25
Q

MOA: Anti-inflammatory effect is mediated by COX-2 inhibition via decreasing platelet production of TXA2, a potent stimulator of platelet aggregation

A. Aspirin (ASA)
B. Ketorolac
C. Indomethacin
D. Celecoxib

A

Aspirin (Acetylsalicylic acid, ASA)

26
Q

Side effect of Aspirin (Acetylsalicylic acid, ASA) due to inhibition of COX-1 and thereby PG synthesis

A

Gi toxicity

27
Q

Side effect is GI toxicity due to inhibition of COX-1 and thereby PG synthesis

A. Aspirin (ASA)
B. Ketorolac
C. Indomethacin
D. Celecoxib

A

Aspirin (Acetylsalicylic acid, ASA)

28
Q

Uncoupler of oxidative phosphorylation and is associated with Reye syndrome in children

A. Aspirin (ASA)
B. Ketorolac
C. Indomethacin
D. Celecoxib

A

Aspirin (Acetylsalicylic acid, ASA)

29
Q

Nonselective but reversible COX inhibitors

A. Aspirin (ASA)
B. Ketorolac
C. Indomethacin
D. Celecoxib

A

Ketorolac
Indomethacin

30
Q

Selective COX-2 inhibitor with a reduced risk of GI toxicity

A. Aspirin (ASA)
B. Ketorolac
C. Indomethacin
D. Celecoxib

A

Celecoxib

31
Q

Hormonal response to injury

Glucocorticoid steroid hormone released by the adrenal cortex in response to adrenocorticotropic hormone (ACTH)

A. Cortisol
B. Macrophage migration-inhibiting factor
C. Growth Hormone (GH)
D. Catecholamines
E. Insulin

A

Cortisol

32
Q

Hormonal response to injury

Released is increased during times of stress and may be chronically elevated in certain disease process (burn-injured patients may exhibit elevated levels for 4 weeks)

A. Cortisol
B. Macrophage migration-inhibiting factor
C. Growth Hormone (GH)
D. Catecholamines
E. Insulin

A

Cortisol

33
Q

Hormonal response to injury

Reduces transforming growth factor-beta (TGF-B) and insulin-like growth factor (IGF-1) so wound repair is impaired

A. Cortisol
B. Macrophage migration-inhibiting factor
C. Growth Hormone (GH)
D. Catecholamines
E. Insulin

A

Cortisol

34
Q

Hormonal response to injury

Neurohormone that is stored and secreted by the anterior pituitary and by the intracellular pools within macrophages

A. Cortisol
B. Macrophage migration-inhibiting factor
C. Growth Hormone (GH)
D. Catecholamines
E. Insulin

A

Macrophage migration-inhibiting factor

35
Q

Hormonal response to injury

A counter regulatory mediator that potentially reverses the anti-inflammatory effects of cortisol

A. Cortisol
B. Macrophage migration-inhibiting factor
C. Growth Hormone (GH)
D. Catecholamines
E. Insulin

A

Macrophage migration-inhibiting factor

36
Q

Hormonal response to injury

Neurohormone expressed primarily by the pituitary gland that has both metabolic and immunomodulatory effects

A. Cortisol
B. Macrophage migration-inhibiting factor
C. Growth Hormone (GH)
D. Catecholamines
E. Insulin

A

Growth hormone

37
Q

Hormonal response to injury

Exerts its downstream effects through direct interaction with GH receptors and secondarily through the enhanced hepatic synthesis

A. Cortisol
B. Macrophage migration-inhibiting factor
C. Growth Hormone (GH)
D. Catecholamines
E. Insulin

A

Growth hormone

38
Q

Hormonal response to injury

Promote protein synthesis and insulin resistance and enhances mobilization of fat stores

A. Cortisol
B. Macrophage migration-inhibiting factor
C. Growth Hormone (GH)
D. Catecholamines
E. Insulin

A

Growth hormone (GH) and Insulin growth factor (IGF-1)

39
Q

Hormonal response to injury

Include epinephrine, norepinephrine, and dopamine which have metabolic, immunomodulatory and vasoactive effects

A. Cortisol
B. Macrophage migration-inhibiting factor
C. Growth Hormone (GH)
D. Catecholamines
E. Insulin

A

Catecholamines

40
Q

Hormonal response to injury

After sever injury, plasma levels of this hormones are increased 3-4x with elevations lasting 24-48h before returning to baseline levels

A. Cortisol
B. Macrophage migration-inhibiting factor
C. Growth Hormone (GH)
D. Catecholamines
E. Insulin

A

Catecholamines

41
Q

Hormonal response to injury

Mediates an overall host anabolic state

A. Cortisol
B. Macrophage migration-inhibiting factor
C. Growth Hormone (GH)
D. Catecholamines
E. Insulin

A

Insulin

42
Q

Hormonal response to injury

Are hallmarks of critical illness due to catabolic effects of circulating mediators including catecholamines, cortisol, glucagon and GH

A

Insulin resistance and hyperglycemia

43
Q

Hormonal response to injury

During critical illness has immunosuppresive effects and thus is associated with an increased risk for infection

A

Hyperglycemia

44
Q

Hormonal response to injury

This therapy to manage hyperglycemia decreased mortality and reduced in infections complications in select patient populations

A

Insulin therapy

45
Q

CNS regulation of inflammation

Nerve highly influential in mediating afferent sensory input to the CNS

A

Vagus nerve

46
Q

CNS regulation of inflammation

Parasympathetic nervous system transmits its efferent signals via this neurotransmitter

A

Acetylcholine

47
Q

CNS regulation of inflammation

Exerts homeostatic influences such as
-enhancing gut mobility
-reducing heart rate
-regulating inflammation

A

Vagus nerve

48
Q

CNS regulation of inflammation

Allows for rapid response to inflammatory stimuli and also for the potential regulation of early proinflammatory mediator release specifically tumor necrosis factor (TNF)

A

Vagus nerve

49
Q

CNS regulation of inflammation

Inhibit cytokine activity and reduce injury from disease process

A

Vagus nerve

50
Q

Burn patients may exhibit elevated levels of this hormone for 4 weeks

A

Cortisol

51
Q

Plasma levels of this hormone are increased 3-4x lasting for 24 to 48 hours before returning to baseline after severe injury

A

Catecholamines